Empowering Physicians and Patients to monitor brain health

Empowering Physicians and Patients to monitor brain health

Empowering Physicians and Patients to monitor brain health

Empowering Physicians and Patients to monitor brain health

A collaboration with Cogstate that leverages human-centered design to transform cognitive assessments

A collaboration with Cogstate that leverages human-centered design to transform cognitive assessments

A collaboration with Cogstate that leverages human-centered design to transform cognitive assessments

A collaboration with Cogstate that leverages human-centered design to transform cognitive assessments

Sector

Sector

Sector

Healthcare

Healthcare

Healthcare

Offering

Offering

Offering

Research / Strategy / Implementation

Research / Strategy / Implementation

Research / Strategy / Implementation

Method

Method

Method

Human-centered Design

Human-centered Design

Human-centered Design

Expertise

Expertise

Expertise

CX / Content Strategy

CX / Content Strategy

CX / Content Strategy

Nearly 7 million Americans age 65 and older are living with Alzheimer’s disease. By 2050, the number is expected to rise to 13 million. Treatments to slow the progression of Alzheimer’s are now available, but they require early detection of the disease. Cognitive assessments can advance early detection but are not widely adopted in the U.S.

Nearly 7 million Americans age 65 and older are living with Alzheimer’s disease. By 2050, the number is expected to rise to 13 million. Treatments to slow the progression of Alzheimer’s are now available, but they require early detection of the disease. Cognitive assessments can advance early detection but are not widely adopted in the U.S.

Nearly 7 million Americans age 65 and older are living with Alzheimer’s disease. By 2050, the number is expected to rise to 13 million. Treatments to slow the progression of Alzheimer’s are now available, but they require early detection of the disease. Cognitive assessments can advance early detection but are not widely adopted in the U.S.

Nearly 7 million Americans age 65 and older are living with Alzheimer’s disease. By 2050, the number is expected to rise to 13 million. Treatments to slow the progression of Alzheimer’s are now available, but they require early detection of the disease. Cognitive assessments can advance early detection but are not widely adopted in the U.S.

Primary Care Physician reviewing a cognitive assessment with an older woman
Elder sitting at kitchen table taking a cognitive assessment on a tablet
Elder sitting at kitchen table taking a cognitive assessment on a tablet

Cogstate is on a mission to tackle this public health crisis by making scientifically valid cognitive assessments simple, accessible, and informative.

Cognigram is one of their crowning achievements. This HIPPA-compliant, FDA Class II exempt digital medical device is powered by the Cogstate Brief Battery, which has been used to effectively monitor brain health in more than 2,000 research studies.

This led the team to wonder: How might we leverage Cognigram to advance the early detection of Alzheimer's disease in doctor's offices and homes across the U.S.?

To this end, Public Works was honored to lead the strategic design of the Cognigram experience.

Cogstate is on a mission to tackle this public health crisis by making scientifically valid cognitive assessments simple, accessible, and informative.


Cognigram is one of their crowning achievements. This HIPPA-compliant, FDA Class II exempt digital medical device is powered by the Cogstate Brief Battery, which has been used to effectively monitor brain health in more than 2,000 research studies.


This led the team to wonder: How might we leverage Cognigram to advance the early detection of Alzheimer's disease in doctor's offices and homes across the U.S.?


To this end, Public Works was honored to lead the strategic design of the Cognigram experience.

Cogstate is on a mission to tackle this public health crisis by making scientifically valid cognitive assessments simple, accessible, and informative.

Cognigram is one of their crowning achievements. This HIPPA-compliant, FDA Class II exempt digital medical device is powered by the Cogstate Brief Battery, which has been used to effectively monitor brain health in more than 2,000 research studies.


This led the team to wonder: How might we leverage Cognigram to advance the early detection of Alzheimer's disease in doctor's offices and homes across the U.S.?


To this end, Public Works was honored to lead the strategic design of the Cognigram experience.

Actions

Insights

Outcomes

Impact

Actions

Insights

Outcomes

Impact

Actions

Insights

Outcomes

Impact

Actions

Insights

Outcomes

Impact

Below Cognigram reframed with insight from Primary Care Physicians and Medicare Patients

Below Cognigram reframed with insight from Primary Care Physicians and Medicare Patients

Below Cognigram reframed with insight from Primary Care Physicians and Medicare Patients

Physican viewing Cognigram website redesign after research
Physican viewing Cognigram website redesign after research
Physican viewing Cognigram website redesign after research

Public Works changed how we thought. And what we were solving for.

We always focused on the scientific validity of our cognitive assessments. We learned that this falls by the wayside if we get the product experience and communication of the results wrong.

Public Works changed how we thought. And what we were solving for.

We always focused on the scientific validity of our cognitive assessments. We learned that this falls by the wayside if we get the product experience and communication of the results wrong.

Public Works changed how we thought. And what we were solving for.

We always focused on the scientific validity of our cognitive assessments. We learned that this falls by the wayside if we get the product experience and communication of the results wrong.

Public Works changed how we thought. And what we were solving for.

We always focused on the scientific validity of our cognitive assessments. We learned that this falls by the wayside if we get the product experience and communication of the results wrong.

Brad O'Connor, CEO
Cogstate

Brad O'Connor, CEO
Cogstate

Brad O'Connor, CEO
Cogstate

Public Works is a strategic design collaborative dedicated to advancing public health.

Assembly required

© 2024 Public Works Collaborative, LLC

Public Works is a strategic design collaborative dedicated to advancing public health.

Assembly required

© 2024 Public Works Collaborative, LLC

Public Works is a strategic design collaborative dedicated to advancing public health.

Assembly required

© 2024 Public Works Collaborative, LLC

Public Works is a strategic design collaborative dedicated to advancing public health.

Assembly required

© 2024 Public Works Collaborative, LLC